Dudediligence.

Opus Genetics, Inc

IRDNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.9MSep ’24$4.3MDec ’24$4.4MMar ’25$2.9MJun ’25$3.1MSep ’25$3.9MDec ’25$2.2MMar ’26$755,000Jun ’26
Net income, by quarter
−$7.5MSep ’24−$35.1MDec ’24−$8.2MMar ’25−$7.4MJun ’25−$17.5MSep ’25−$16.5MDec ’25−$65.5MMar ’26−$8.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$589,000$39.9M$19.0M$11.0M$14.2M
Operating income−$22.7M$18.2M−$10.6M−$62.1M−$38.6M
Net income−$56.7M$17.9M−$10.0M−$57.5M−$49.6M
Operating cash flow−$19.4M$14.3M−$1.1M−$25.6M−$35.3M
Cash$24.5M$42.6M$50.5M$30.3M$45.1M
Debt$538,000$0.00none on file$0.00$1.1M
Shares outstanding18.8M20.9M24.0M31.6M69.9M